![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1667194
ÀüÀÚó¹æÀü ½ÃÀå ±âȸ, ¼ºÀå ÃËÁø¿äÀÎ, »ê¾÷ µ¿Ç⠺м®, ¿¹Ãø(2025-2034³â)e-prescribing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
¼¼°è ÀüÀÚó¹æÀü ½ÃÀåÀº 2024³â 26¾ï ´Þ·¯·Î Æò°¡µÇ¸ç, 2025³âºÎÅÍ 2034³â±îÁö ¿¬Æò±Õ 22.6%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀå¿¡´Â µðÁöÅÐ Çコ ¼Ö·ç¼ÇÀÇ ºü¸¥ äÅÃ, ¿ø°ÝÀÇ·á¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡, Åõ¾à ½Ç¼ö ÃÖ¼ÒÈ ¹× ÀÇ·á »ç±â ¹æÁö¿¡ ´ëÇÑ °ü½É Áõ°¡°¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀüÀÚó¹æÀü ½Ã½ºÅÛÀº ó¹æÀü °ü¸®¿¡ Çõ¸íÀ» ÀÏÀ¸ÄÑ ÀÇ·á ¼ºñ½º Á¦°øÀÇ Á¤È®¼º, È¿À²¼º, ȯÀÚ ¾ÈÀü¼ºÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÇ·á ¼ºñ½º Á¦°øÀÚµéÀÌ µðÁöÅÐ ÀüȯÀ» Á¡Á¡ ´õ ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ´Â °¡¿îµ¥, Çõ½ÅÀûÀÎ ±â¼úÀÇ ÅëÇÕÀº Çö´ë ÀÇ·á ÇàÀ§ÀÇ Çʼö ¿ä¼Ò·Î ÀÚ¸® Àâ°í ÀÖ½À´Ï´Ù.
ÀüÀÚó¹æÀü Ç÷§ÆûÀº ÀüÀڰǰ±â·Ï(EHR)°úÀÇ ¿Ïº®ÇÑ ÅëÇÕÀ» ÅëÇØ ÀÇ·áÁøÀÌ º´·Â, ¾Ë·¹¸£±â, ÇöÀç º¹¿ë ÁßÀÎ ¾à¹° µî Á¾ÇÕÀûÀΠȯÀÚ µ¥ÀÌÅÍ¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÓ»óÀû ÀÇ»ç°áÁ¤À» Áö¿øÇϰí, ¿öÅ©Ç÷ο츦 °£¼ÒÈÇϸç, ¾à¹° ºÎÀÛ¿ëÀÇ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÀÇ·á ¼ºñ½º Á¦°øÀÚ °£ÀÇ Çù¾÷À» °ÈÇÏ¿© ȯÀÚ Ä¡·á¿¡¼ ´õ ³ªÀº Çù¾÷À» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. Àü ¼¼°èÀûÀ¸·Î Á¤ºÎ¿Í ÀÇ·á ±â°üÀÌ µðÁöÅÐÈ¿¡ ´ëÇÑ Á߿伺À» °Á¶ÇÏ´Â °¡¿îµ¥, ÀüÀÚó¹æÀü ¼Ö·ç¼ÇÀº ÀÇ·á ÀÎÇÁ¶ó Çö´ëÈ¿¡ ÇʼöÀûÀÎ ¿ªÇÒÀ» ÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.
½ÃÀå ¹üÀ§ | |
---|---|
½ÃÀÛ ¿¬µµ | 2024³â |
¿¹Ãø ¿¬µµ | 2025-2034³â |
½ÃÀÛ ±Ý¾× | 26¾ï ´Þ·¯ |
¿¹»ó ±Ý¾× | 195¾ï ´Þ·¯ |
CAGR | 22.6% |
¼Ö·ç¼Ç°ú ¼ºñ½º·Î ºÐ·ùµÇ´Â ÀÌ ½ÃÀåÀº 2024³â ¼Ö·ç¼ÇÀÌ 68.9%ÀÇ ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, ÀÌ´Â °·ÂÇÑ ¾à¹° °ü¸® µµ±¸¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ó¹æÀü ¿À·ù¸¦ ÁÙÀ̱â À§ÇÑ ³ë·Â¿¡ ±âÀÎÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ÅëÇÕÇü°ú µ¶¸³Çü ¼Ö·ç¼ÇÀ¸·Î ³ª´µ¸ç, ÀÇ·á ¼ºñ½º Á¦°øÀÚÀÇ ´Ù¾çÇÑ ¿ä±¸¿¡ ´ëÀÀÇÕ´Ï´Ù. ÅëÇÕÇü ¼Ö·ç¼ÇÀº Á¾ÇÕÀûÀÎ ±â´É°ú ±âÁ¸ ½Ã½ºÅÛ°úÀÇ »óÈ£¿î¿ë¼ºÀ» Á¦°øÇÑ´Ù´Â Á¡¿¡¼ ÀαⰡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ¹Ý¸é, µ¶¸³Çü ¼Ö·ç¼ÇÀº ¼Ò±Ô¸ð Áø·á¼Ò³ª Ŭ¸®´ÐÀÇ Æ´»õ ¿ä±¸»çÇ×À» ÃæÁ·ÇÏ´Â µ¥ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù.
¼ºñ½º ¶ÇÇÑ ½ÃÀåÀÇ Áß¿äÇÑ ±¸¼º¿ä¼Ò·Î, Áö¿ø, À¯Áöº¸¼ö, µµÀÔ, ³×Æ®¿öÅ·, ±³À° ¼ºñ½º µîÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼ºñ½º´Â ÇコÄÉ¾î ºÎ¹®ÀÇ ¿ªµ¿ÀûÀÎ ¼ö¿ä¸¦ ÃæÁ·½ÃŰ¸é¼ ÀüÀÚó¹æÀü ½Ã½ºÅÛÀÇ ¿øÈ°ÇÑ ±¸Ãà°ú ¿î¿µÀ» º¸ÀåÇÕ´Ï´Ù. ¼ºñ½º Á¦°ø¾÷ü´Â Áö¼ÓÀûÀÎ ±â¼ú Áö¿ø°ú ½Ã½ºÅÛ ¾÷µ¥ÀÌÆ®¸¦ Á¦°øÇÔÀ¸·Î½á ÀÇ·á ±â°üÀÌ ÃÖÀûÀÇ ¼º´ÉÀ» À¯ÁöÇÏ°í º¯ÈÇÏ´Â ±ÔÁ¤À» ÁؼöÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÕ´Ï´Ù.
Àü°³¸¦ ±âÁØÀ¸·Î º¼ ¶§, ½ÃÀå¿¡´Â À¥ ¹× Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç°ú ¿ÂÇÁ·¹¹Ì½º ½Ã½ºÅÛÀÌ Æ÷ÇԵǸç, À¥ ¹× Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼ÇÀº Àú·ÅÇÑ °¡°Ý, È®À强 ¹× »ç¿ë ÆíÀǼºÀ» ¹Ý¿µÇÏ¿© 2024³â 69.4%ÀÇ ½ÃÀå Á¡À¯À²·Î ¿ìÀ§¸¦ Â÷ÁöÇß½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº °í°¡ÀÇ Çϵå¿þ¾î³ª ÀÎÇÁ¶ó¸¦ ÇÊ¿ä·Î ÇÏÁö ¾Ê±â ¶§¹®¿¡ Áß¼Ò±Ô¸ðÀÇ Áø·á¼Ò¿¡ ƯÈ÷ ¸Å·ÂÀûÀÔ´Ï´Ù. »óÈ£ ¿î¿ë¼º°ú ¿ø°Ý ¾×¼¼½º ±â´ÉÀ» ÅëÇØ ÀÇ·á ¼ºñ½º Á¦°øÀڴ ȯÀÚÀÇ ¾ÈÀü°ú ¸¸Á·µµ¸¦ ³ôÀÌ¸é¼ Ã³¹æÀüÀ» È¿À²ÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¹Ì±¹Àº 2024³â 9¾ï 5,030¸¸ ´Þ·¯ÀÇ ½ÃÀåÀ» âÃâÇßÀ¸¸ç, ÀÌ´Â ÇコÄɾîÀÇ µðÁöÅÐȸ¦ ÃËÁøÇÏ´Â ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¿¬¹æ Á¤ºÎÀÇ Àǹ«È¿Í ÀçÁ¤Àû Àμ¾Æ¼ºê°¡ EHR ¹× ÀüÀÚó¹æÀü µµÀÔ¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖÀ¸¸ç, ¾ö°ÝÇÑ ±ÔÁ¤ Áؼö ¿ä°Ç°ú µ¥ÀÌÅÍ º¸¾È¿¡ ´ëÇÑ °ÇÑ ÁýÂøÀÌ ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý ¼Ö·ç¼Ç°ú AI ±â¹Ý µµ±¸ÀÇ »ç¿ëÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀüÀÚó¹æÀü ½ÃÀåÀº ¾à¹° °ü¸®¸¦ Çõ½ÅÇϰí ÀÇ·á ½Ã½ºÅÛ Àü¹Ý¿¡ °ÉÃÄ È¯ÀÚ Ä¡·á °á°ú¿Í ¾÷¹« È¿À²¼ºÀ» °³¼±ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.
The Global E-Prescribing Market, valued at USD 2.6 billion in 2024, is projected to expand at a CAGR of 22.6% between 2025 and 2034. This growth is fueled by the rapid adoption of digital health solutions, increasing awareness of telemedicine, and a heightened focus on minimizing medication errors and preventing healthcare fraud. E-prescribing systems are revolutionizing prescription management, enhancing accuracy, efficiency, and patient safety in healthcare delivery. As healthcare providers increasingly prioritize digital transformation, the integration of innovative technologies is becoming a critical component of modern medical practices.
E-prescribing platforms enable healthcare professionals to access comprehensive patient data, including medical history, allergies, and current medications, through seamless integration with electronic health records (EHRs). This integration supports informed clinical decision-making, streamlines workflows, and reduces the risk of adverse drug events. These systems also foster enhanced collaboration among providers, allowing for better coordination in patient care. With governments and healthcare organizations globally emphasizing digitalization, e-prescribing solutions are poised to play an essential role in the modernization of healthcare infrastructure.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $2.6 Billion |
Forecast Value | $19.5 Billion |
CAGR | 22.6% |
The market is categorized into solutions and services. Solutions accounted for a significant 68.9% market share in 2024, driven by the growing demand for robust medication management tools and efforts to reduce prescription errors. These solutions are divided into integrated and standalone options, catering to the diverse needs of healthcare providers. Integrated solutions have become increasingly popular, offering comprehensive functionality and interoperability with existing systems. Meanwhile, standalone solutions address niche requirements for smaller practices and clinics.
Services also form a critical component of the market, encompassing support and maintenance, implementation, networking, and training services. These offerings ensure the smooth deployment and operation of e-prescribing systems while addressing the dynamic demands of the healthcare sector. By providing ongoing technical support and system updates, service providers help healthcare organizations maintain optimal performance and compliance with evolving regulations.
Based on deployment, the market includes web and cloud-based solutions and on-premise systems. Web and cloud-based solutions dominated with a 69.4% market share in 2024, reflecting their affordability, scalability, and ease of use. These solutions eliminate the need for costly hardware and infrastructure, making them particularly attractive to small and mid-sized practices. Their interoperability and remote access capabilities allow healthcare providers to manage prescriptions efficiently while enhancing patient safety and satisfaction.
The United States generated USD 950.3 million in 2024, driven by regulatory frameworks that promote healthcare digitalization. Federal mandates and financial incentives have accelerated the adoption of EHRs and e-prescribing systems, while strict compliance requirements and a strong focus on data security further bolster market growth. With the increasing use of cloud-based solutions and AI-powered tools, the e-prescribing market is set to transform medication management, ensuring improved patient outcomes and operational efficiency across healthcare systems.